Glucagon-like peptide receptor agonists (GLP-1RAs) as cardiovascular risk modifiers in obstructive sleep apnea and obesity: a real-world study Article

sustainable development goals

publication date

  • July 1, 2026

webpage

published in

keywords

  • Cardiovascular risk
  • GLP-1 RA
  • Glucagon-like peptide-1 receptor agonists
  • Obstructive sleep apnea

volume

  • 22

issue

  • 1